William Edward Tausend, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3901 Woodlawn Ave, Pasadena, TX 77504 Phone: 713-946-2666 |
Dr. Manuel Davila, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 Fax: 281-991-6129 |
Whitney Anne Latin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5125 Preston Ave # 150, Pasadena, TX 77505 Phone: 281-991-0737 Fax: 281-991-0738 |
Dr. Paula F Leis, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 Fax: 281-991-6129 |
Dr. Mary Elizabeth Garman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 Fax: 281-991-6849 |
Christine M Hunt, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 |
Dr. Lawrence M. Joseph, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 Fax: 281-991-6849 |
Prof. Wendy C Magee, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 Fax: 281-991-6849 |
Dr. Ashkan John Ghorbani, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 Fax: 281-991-6129 |
Matthew Sean Petitt, DO Dermatology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 |
Isha Lopez, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 Fax: 281-991-6129 |
News Archive
A test for four blood proteins may provide a less-invasive follow-up for patients who have suspicious lesions on chest radiographs or computerized tomography (CT) scans, according to a new study led by Duke University Medical Center researchers.
Exelixis, Inc. today announced that its partner Ipsen Biopharmaceuticals Canada Inc. received approval from Health Canada of CABOMETYX® tablets for the treatment of adults with advanced renal cell carcinoma who have received prior vascular endothelial growth factor targeted therapy.
In this analysis we brought together the few European studies that have looked, within geographical areas, at the prevalence or incidence of dementia in the population aged 65 and over.
World-leading scientists, ethicists, policymakers, and cancer patient advocates will gather at Arizona State University for the first-ever Prophylactic Cancer Vaccine Conference in Tempe, Ariz., March 16-18, 2011. The conference will be a premier forum to discuss the latest developments in a radical new approach to battling cancer: the development of cancer vaccines aimed at protecting healthy individuals from the disease.
› Verified 6 days ago